Synaptic Actions of Amphetamine in the Striatum

安非他明在纹状体中的突触作用

基本信息

项目摘要

Project summary Addictive psychostimulants such as amphetamine act at dopamine synapses in the striatum. Presynaptic amphetamine action drives dopamine release via activity-dependent and activity-independent mechanisms. Dopamine acts on multiple dopamine receptors that are differentially distributed on striatal neurons. Beyond this volume transmission, dopamine neurons engage in synaptic transmission that is operative on a fast time scale, compared to volume transmission, and involves not only dopamine, but also GABA and glutamate. This project focuses on these synaptic connections as a novel substrate for psychostimulant action. The synaptic transmission exerts excitatory effects through dopamine D1 receptors, ionotropic and metabotropic glutamate receptors, and inhibitory effects through dopamine D2 receptors and GABAA receptors. While dopaminergic and GABAergic synaptic connections are widespread, glutamatergic connections are concentrated in the medial nucleus accumbens and the anterior lateral dorsal striatum. Synaptic connections to cholinergic interneurons are the strongest, most complex, involving dopamine, GABA and glutamate. Remarkably glutamate cotransmission is abrogated by amphetamine administration, and abrogation of glutamate cotransmission attenuates psychostimulant responsiveness. The guiding hypothesis is that amphetamine- induced plasticity of a subset of dopamine neuron synapses is critical for driving the striatal circuitry towards the addicted state, particularly dopamine neuron synapses distinguished by glutamate cotransmission. The three specific aims are to: <1> Determine quantitatively amphetamine-induced plasticity of dopamine neuron synaptic connections to cholinergic interneurons in striatal subregions identified by synaptic connectivity-based clustering. <2> Determine direct synaptic effects of amphetamine on dopamine neuron synaptic transmission in striatal subregions distinguished by glutamate cotransmission. <3> Determine amphetamine effects on dopamine neuron terminal activity during amphetamine-induced behaviors. This project will advance understanding of the synaptic substrate of amphetamine action in the striatum, revealing loci of drug-induced plasticity that will inform the pharmacotherapy of addiction.
项目摘要 成瘾性精神兴奋剂,如安非他明,作用于纹状体中的多巴胺突触。突触前 安非他明作用通过活性依赖性和活性非依赖性机制驱动多巴胺释放。 多巴胺作用于纹状体神经元上差异分布的多种多巴胺受体。超出 在这种体积传递中,多巴胺神经元参与突触传递, 规模,相比体积传输,不仅涉及多巴胺,但也GABA和谷氨酸。这 项目的重点是这些突触连接作为一种新的基板精神兴奋剂的行动。突触 传递通过多巴胺D1受体、离子型和代谢型谷氨酸发挥兴奋作用 受体,以及通过多巴胺D2受体和GABAA受体的抑制作用。虽然多巴胺能 GABA能突触连接广泛分布,谷氨酸能连接集中在 内侧核和前外侧背侧纹状体。与胆碱能神经的突触连接 中间神经元是最强、最复杂的,涉及多巴胺、GABA和谷氨酸。显著 谷氨酸共传递被安非他明给药消除,谷氨酸共传递的消除 共传递减弱了精神兴奋性反应。我们的假设是安非他明- 多巴胺神经元突触子集的诱导可塑性对于驱动纹状体回路朝向 成瘾状态,特别是以谷氨酸共传递为特征的多巴胺神经元突触。的 三个具体目标是:<1>定量测定安非他明诱导的多巴胺神经元的可塑性 基于突触连接性的纹状体亚区胆碱能中间神经元的突触连接 聚类<2>确定苯丙胺对多巴胺神经元突触传递的直接突触效应 在纹状体亚区区分谷氨酸共传输。<3>确定安非他明对 多巴胺神经元末梢活动在安非他明诱导的行为。该项目将推进 理解纹状体中安非他明作用的突触底物,揭示药物诱导的 可塑性,将告知药物治疗成瘾。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN RAYPORT其他文献

STEPHEN RAYPORT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN RAYPORT', 18)}}的其他基金

Targeting cotransmission for circuit-specific pharmacotherapy
针对回路特异性药物治疗的共传输
  • 批准号:
    10410440
  • 财政年份:
    2018
  • 资助金额:
    $ 56.21万
  • 项目类别:
Targeting cotransmission for circuit-specific pharmacotherapy
针对回路特异性药物治疗的共传输
  • 批准号:
    10212915
  • 财政年份:
    2018
  • 资助金额:
    $ 56.21万
  • 项目类别:
Targeting cotransmission for circuit-specific pharmacotherapy
针对回路特异性药物治疗的共传输
  • 批准号:
    9769150
  • 财政年份:
    2018
  • 资助金额:
    $ 56.21万
  • 项目类别:
Mapping dopamine neuron cotransmission by proximity detection
通过邻近检测绘制多巴胺神经元共传递
  • 批准号:
    8985749
  • 财政年份:
    2015
  • 资助金额:
    $ 56.21万
  • 项目类别:
Functional connectome analysis of amphetamine action at dopamine neuron synapses
安非他明对多巴胺神经元突触作用的功能连接组分析
  • 批准号:
    8913460
  • 财政年份:
    2015
  • 资助金额:
    $ 56.21万
  • 项目类别:
Functional connectome analysis of amphetamine action at dopamine neuron synapses
安非他明对多巴胺神经元突触作用的功能连接组分析
  • 批准号:
    9231430
  • 财政年份:
    2015
  • 资助金额:
    $ 56.21万
  • 项目类别:
Functional connectome analysis of amphetamine action at dopamine neuron synapses
安非他明对多巴胺神经元突触作用的功能连接组分析
  • 批准号:
    9054105
  • 财政年份:
    2015
  • 资助金额:
    $ 56.21万
  • 项目类别:
Therapeutic potential of GLS1 inhibition for the pharmacotherapy of schizophrenia
GLS1 抑制在精神分裂症药物治疗中的治疗潜力
  • 批准号:
    7767107
  • 财政年份:
    2010
  • 资助金额:
    $ 56.21万
  • 项目类别:
Therapeutic potential of GLS1 inhibition for the pharmacotherapy of schizophrenia
GLS1 抑制在精神分裂症药物治疗中的治疗潜力
  • 批准号:
    8403407
  • 财政年份:
    2010
  • 资助金额:
    $ 56.21万
  • 项目类别:
Therapeutic potential of GLS1 inhibition for the pharmacotherapy of schizophrenia
GLS1 抑制在精神分裂症药物治疗中的治疗潜力
  • 批准号:
    8210963
  • 财政年份:
    2010
  • 资助金额:
    $ 56.21万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 56.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了